The NF-κB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia

This publication has 51 references indexed in Scilit:

• Proteasome Inhibitor PS519 Reduces Infarction and Attenuates Leukocyte Infiltration in a Rat Model of Focal Cerebral Ischemia
  Stroke, 2000
• N‐Acetylcysteine suppresses TNF‐induced NF‐κB activation through inhibition of IκB kinases
  FEBS Letters, 2000
• Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-κB activation
  NeuroReport, 2000
• The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosis
  Genes & Development, 1999
• Inhibition of nuclear factor κB attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1998
• Transcription factor NF-κB: friend or foe of neurons?
  Molecular Psychiatry, 1998
• An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
  Science, 1996
• Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
  Nature, 1994
• Reversible middle cerebral artery occlusion without craniectomy in rats.
  Stroke, 1989
• Influence of rat brain superoxide dismutase inhibition by diethyldithiocarbamate upon the rate of development of central nervous system oxygen toxicity
  Toxicology and Applied Pharmacology, 1984